Relation of 99mTc-sestamibi washout with myocardial properties in patients with hypertrophic cardiomyopathy

Journal of Nuclear Cardiology

Volumn 17, Issue 6, 2010, Pages 1082-1090

  Isobe, Satoshi ^a,b   Ohshima, Satoru ^b   Unno, Kazumasa ^b   Izawa, Hideo ^c   Kato, Katsuhiko ^d   Noda, Akiko ^d   Hirashiki, Akihiro ^b   Murohara, Toyoaki ^b  

^a Kami iida Daiichi General Hospital   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Contractility; Hypertrophic cardiomyopathy; Relaxation; Tc sestamibi scintigraphy; Washout rate

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM PACING; HEART CATHETERIZATION; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE RELAXATION; HEMODYNAMIC MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; AGED; HEART CONTRACTION; HEART MUSCLE; HEART VENTRICLE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PRESSURE; PROGNOSIS; SCINTISCANNING;

AGED; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; PRESSURE; PROGNOSIS; TECHNETIUM TC 99M SESTAMIBI;

EID: 78651296262     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-010-9266-7     Document Type: Article

References (23)

1. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979;43:1242-4.
2. Betocchi S, Bonow RO, Bacharach SL, Rosing DR, Maron BJ, Green MV. Isovolumic relaxation period in hypertrophic cardio- myopathy: Assessment by radionuclide angiography. J Am Coll Cardiol 1986;7:74-81.
3. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochon- drial and plasma membrane potentials on accumulation of hexakis (2- methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646-53.
4. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium- 99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998;39:266-71.
5. Morishita S, Kondo Y, Nomura M, Miyajima H, Nada T, Ito S, et al. Impaired retention of technetium-99m tetrofosmin in hypertrophic cardiomyopathy. Am J Cardiol 2001;87:743-7.
6. Izawa H, Yokota M, Takeichi Y, Inagaki M, Nagata K, Iwase M, et al. Adrenergic control of the force-frequency and relaxation- frequency relations in patients with hypertrophic cardiomyopathy. Circulation 1997;96:2959-68.
7. Somura F, Izawa H, Iwase M, Takeichi Y, Ishiki R, Nishizawa T, et al. Reduced myocardial sarcoplasmic reticulum Ca2+-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy. Circulation 2001; 104:658-63.
8. Isobe S, Izawa H, Takeichi Y, Nonokawa M, Nanasato M, Ando A, et al. Relationship between exercise-induced myocardial ischemia and reduced left ventricular distensibility in patients with nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2003;44:1717-24.
9. Isobe S, Izawa H, Iwase M, Nanasato M, Nonokawa M, Ando A, et al. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2005;46:909-16.
10. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/ International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996;93:841-2.
11. Henry WL, Clark CE, Epstein SE. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 1973;47:225-33.
12. Ohshima S, Isobe S, Izawa H, Nanasato M, Ando A, Yamada A, et al. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients. J Am Coll Cardiol 2005;46:2061-8.
13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
14. Takeishi Y, Sukekawa H, Fujiwara S, Ikeno E, Sasaki Y, Tomoike H. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction. J Nucl Med 1996;37:1289-94.
15. Sugiura T, Takase H, Toriyama T, Goto T, Ueda R, Dohi Y. Usefulness of Tc-99m methoxyisobutylisonitrile scintigraphy for evaluating congestive heart failure. J Nucl Cardiol 2006;13:64-8.
16. Thet-Thet-Lwin, Takeda T, Wu J, Fumikura Y, Iida K, Kawano S, et al. Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: Quantitative comparisons with regional 123I- BMIPP uptake and wall thickness determined by MRI. Eur J Nucl Med Mol Imaging 2003;30:966-73.
17. Hirasaki S, Nakamura T, Kuribayashi T, Shima T, Matsubara K, Azuma A, et al. Abnormal course, abnormal flow, and systolic compression of the septal perforator associated with impaired myocardial perfusion in hypertrophic cardiomyopathy. Am Heart J 1999;137:109-17.
18. Ohtsuki K, Sugihara H, Kuribayashi T, Nakagawa M. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. J Nucl Med 1999;40:2007-13.
19. Takeichi Y, Yokota M, Iwase M, Izawa H, Nishizawa T, Ishiki R, et al. Biphasic changes in left ventricular end-diastolic pressure during dynamic exercise in patients with nonobstructive hyper- trophic cardiomyopathy. J Am Coll Cardiol 2001;38:335-43.
20. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.
21. Cannon RO III, Schenke WH, Maron BJ, Tracy CM, Leon MB, Brush JE Jr, et al. Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardio- myopathy. J Am Coll Cardiol 1987;10:53-62.
22. Udelson JE, Cannon RO III, Bacharach SL, Rumble TF, Bonow RO. Beta-adrenergic stimulation with isoproterenol enhances left ventricular diastolic performance in hypertrophic cardiomyopathy despite potentiation of myocardial ischemia. Comparison to rapid atrial pacing. Circulation 1989;79:371-82.
23. Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric magnetic resonance imaging. Circulation 2007;115:2418-25.